Drugs & Targets EC approves Opdivo + Yervoy for adults in dMMR or MSI-H metastatic colorectal cancer indication July 02, 2021Vol.47 No.26
Drugs & Targets EC approves Keytruda + chemo for esophageal cancer or HER2-negative gastroesophageal junction adenocarcinoma July 02, 2021Vol.47 No.26
Drugs & Targets EC approves Libtayo for first-line treatment of advanced NSCLC with ≥50% PD-L1 expression July 02, 2021Vol.47 No.26
NCI Biden’s budget request for NCI would set back Sharpless’s goal of raising R01 paylines to 15% June 18, 2021Vol.47 No.24By Alexandria Carolan
Trials & Tribulations Annals of Unintended Consequences: How FDA regulations undermine the biosimilar marketplace and the BPCIA June 18, 2021Vol.47 No.24By Howard S. Hochster and Michael P. Kane
In Brief Suresh S. Ramalingam named executive director of Winship Cancer Institute June 18, 2021Vol.47 No.24
In Brief Conquer Cancer names 2021 ASCO annual meeting Merit Award recipients June 18, 2021Vol.47 No.24
